Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$91.91 - $110.37 $597,415 - $717,405
-6,500 Closed
0 $0
Q2 2021

Aug 03, 2021

BUY
$86.24 - $95.92 $265,360 - $295,145
3,077 Added 89.89%
6,500 $609,000
Q1 2021

May 10, 2021

BUY
$71.83 - $95.48 $5,818 - $7,733
81 Added 2.42%
3,423 $315,000
Q4 2020

Feb 11, 2021

SELL
$67.0 - $84.39 $39,932 - $50,296
-596 Reduced 15.13%
3,342 $244,000
Q3 2020

Nov 13, 2020

BUY
$55.23 - $79.93 $2,485 - $3,596
45 Added 1.16%
3,938 $306,000
Q2 2020

Aug 11, 2020

BUY
$30.2 - $56.98 $117,568 - $221,823
3,893 New
3,893 $216,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.